NEW YORK, Nov. 02, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Quorum Health Corporation securities (NYSE:QHC) from May 2, 2016 through August 10, 2016 of the important November 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Quorum investors under the federal securities laws.
To join the Quorum class action, go to the firm’s website at http://www.rosenlegal.com/cases-935.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) a number of Quorum’s hospitals were underperforming at the time of the spin-off from Community Health Systems, Inc. (“CHS”); (2) various other indicators of impairment existed at the time of Quorum’s spin-off from CHS; (3) Quorum disregarded and/or failed to advise investors of the foregoing issues; and (3) as a result, Quorum’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 8, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-935.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected]. Attorney Advertising. Prior results do not guarantee a similar outcome.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



